VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
1.070
0.00 (0.00%)
At close: Apr 15, 2025, 4:00 PM
1.074
+0.004 (0.38%)
After-hours: Apr 15, 2025, 6:00 PM EDT
Company Description
VSee Health, Inc. provides telehealth care solutions.
The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions.
Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
VSee Health, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 40 |
| CEO | M.D. Dr. Imoigele P. Aisiku M.B.A. |
Contact Details
Address: One Gateway Center, Suite 507 Newton, Massachusetts 02458 United States | |
| Website | vseehealth.com |
Stock Details
| Ticker Symbol | VSEE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001864531 |
| ISIN Number | US92919Y1029 |
| Employer ID | 86-2970927 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Milton Chen Ph.D. | Co-Chief Executive Officer and Director |
| Dr. Imoigele P. Aisiku M.B.A., M.D. | Chairman of the Board and Co-Chief Executive Officer |
| Jerry Leonard CPA, M.B.A. | Chief Financial Officer, Secretary and Senior Vice President of Business Development |
| Erika Chuang Ph.D. | Chief of Products |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 21, 2025 | 8-K | Current Report |
| Jan 30, 2025 | 8-K | Current Report |
| Jan 27, 2025 | 8-K | Current Report |
| Jan 16, 2025 | 8-K | Current Report |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 18, 2024 | 8-K | Current Report |
| Dec 11, 2024 | 8-K | Current Report |
| Nov 26, 2024 | EFFECT | Notice of Effectiveness |
| Nov 26, 2024 | 424B3 | Prospectus |